stroke
Label
Huntington Disease (HD)
Definition &CausesSymptomsInvestigations & TreatmentsRisk Factors & PreventionOutcome
Definition and Causes:

Huntington disease (HD) is a disorder passed down through families in which certain areas of the brain undergo degeneration (progressive break down) of nerve cells, called neurons. It is a slowly progressive disease characterized by abnormal movements, loss of intellectual faculties such as thinking (cognitive decline), and emotional disturbance (psychiatric symptoms).

 

HD is typically noticeable in 3rd & 4th decade of life.

 

If the disease begins before the age of 20, it is called juvenile Huntington disease, and may present differently with rapid progression in the disease course.

 

Causes:

It is a familial (genetic) disease, passed from parent to child through a mutated gene (called a gene mutation).

 

  • Genes are composed of deoxyribonucleic acid, i.e. DNA
  • DNA is shaped like a spiral ladder; each ladder is made up of 2 paired chemicals known as bases
  • There are 4 types of bases
    • Adenine (A)
    • Thymine (T)
    • Cytosine(C)
    • Guanine (G)

 

1-Image-Causes-DNA-HD

 

These bases are paired in combinations to form a coded message. A gene is a long string of this DNA in various unique combinations of paired bases determining the gene function, i.e. the code or genes give us our characteristics, e.g. height, hair texture etc.).

 

  • There are about 30,000 genes in an individual

 

  • Genes are arranged in specific locations along the 23 pairs of chromosomes of each parent

 

  • Gene can be dominant or recessive

 

The HD gene is called an autosomal dominant gene. This means it can be easily passed to the offspring even if only one parent has the gene.

 

If one parent is affected each child in the family, has at least 50 percent chance of inheriting the gene that causes the genetic disorder.

 

If a child does not inherit the HD gene, he or she will not develop the disease and cannot pass it to subsequent generations.

 

Autosomal Dominant Disorder

2-Image-Causes-Autosomal Dominant-HD

 

Back to Top
Symptoms:

During the course of the disease the development of symptoms varies from patient to patient; symptoms are easily divided into:

 

1) Movement disorders:

The ability to produce and control movement is affected.

 

  • Involuntary jerking or writhing movements (chorea)
  • Involuntary, sustained contracture of muscles (dystonia)
  • Muscle rigidity/spasticity
  • Impaired gait, posture and balance
  • Uncoordinated fine movements
  • Eye movements (slow/abnormal)
  • Speech and swallowing difficulties

 

2) Cognitive disorders (category of mental health

disorders that affect learning, memory, perception, and problem solving skills) such as:

 

  • Poor concentration; easily distracted
  • Inability to start a task or conversation
  • Difficulty planning, organizing and prioritizing tasks
  • Difficulty in multitasking
  • Rigid, inflexible thoughts
  • Outbursts, acting without thinking and sexual promiscuity
  • Problems with spatial perception that can result in falls, clumsiness or accidents
  • Difficulty in learning new information

 

3) Psychiatric disorders (mental disorders effecting

behaviour associated with distress or disability), such as:

 

  • Feelings of sadness or unhappiness (depression)
  • Social isolation
  • Disrupted sleep pattern
  • Feelings of worthlessness or guilt
  • Suicidal ideation
  • Changes in appetite
  • Reduced sex drive
  • Hallucination
  • Paranoia

 

Back to Top
Investigations and Treatment:

INVESTIGATION:

The detection of the disease (diagnosis) is assisted by:

  • Development of clinical symptoms (as above)
  • Positive family history
  • Genetic testing: Testing for something called CAG expansions helps to confirm the diagnosis

 

The physician will take a history including the family history and will perform a simple but detailed physical and neurological examination to check the muscle reflexes, strength/tone, hearing, eye movements, coordination balance and mood and mental status; to decide if the psychiatric referral is required.

 

If the clinical suspicion is strong even without a positive family history, genetic may be advised.

 

Imaging:

To assess the structure/function of the brain

 

  • Magnetic resonance image (MRI) brain: This machine uses magnetic field over the body. The device looks like a long cylindrical tube. The patient lies on a table which slides into the cylindrical tube. Computer analysis of magnetic field generates 3-D images of the internal structures of the brain. These images may reveal changes at particular sites in the brain affected by Huntington disease, though they may not be apparent early in the course of the disease. The patient must lie still for about 30-60 minutes within the scanner. Patients who complain of claustrophobia or are uncomfortable in closed spaces may require mild sedatives to help relax

 

  • Electroencephalogram (EEG): May be required in case the physician suspects the patient has experienced any seizure activity. Multiple wires containing tiny metal plates (electrode) at one end are placed over different points on the scalp. The other end being hooked to a computer, records the electrical activity of the brain on the screen or the paper as wavy lines. Abnormal brain activity (such as seizures) can be detected by observing the changes in the normal pattern.

Back to Title

Genetic counselling and testing:

The physician may recommend a genetic test for the defective gene. This test can confirm the diagnosis. Consultation with a genetic counsellor before undergoing genetic testing may be helpful.

 

The test only provides conformation of having a disease, and does not provide information for treatment strategies.

 

Predictive genetic testing (PGT):

Is offered:

  • To people who have positive family history of the disease, but shows no signs or symptoms

Reminder: The test result has

  • No treatment benefit
  • No indication when disease will begin or what symptoms are likely to appear first

Reason to do PGT:

  • Some people are more stressed not knowing
  • Prior to having children. This may help indicate the risk of developing HD and also transferring the gene to children

 

TREATMENT:

There is no cure for the disease. The goal is to slow down the progression of disease symptoms and help the person function normally for as long as possible:

 

Treatment Strategy:

  • Non-medicinal treatment
  • Treatment with medicines

 

Non-medicinal treatment:

Can be used to assist physical disabilities and mental conditions and includes:

 

  • Physiotherapy: Improve/maintain posture, strength, coordination, balance, gait

 

  • Occupational therapy: Assess for safety and need for assistive devices. Improve ambulation, avoid falls, and improve nutrition (eating)

 

  • Speech therapy: Improve/maintain speech and swallowing

 

  • Psychological therapy: Counsel patient and family members; assist with coping with skills

 

  • Social work support: Help family prepare for deteriorating clinical course
    • Assist with arrangements for (full time) supervision as required
    • Suggest and assist with identification of alternate living arrangements (assisted living, nursing home) if required

 

Treatment with medicines:

 

A) Medications for physical symptoms (Movement

disorder):

 

  • Chorea (KO-Ree-AH): Is a brief, irregular movement, which is not repetitive or rhythmic but the movement appears to follow from one muscle to the next. A prominent movement disorder of HD which changes overtime, it eventually peaks and then begins to decline. Treatment is initiated when chorea begins to interfere with voluntary activities like writing, cooking, eating or causes injury due to fall or accidents. It is worsened by stress, anxiety, depression and lack of sleep

 

  • Akathisia (Ah-Ka-Te-See-AH): An extremely uncomfortable sense of restlessness, sometimes induced by the drugs used to treat chorea, depending on the course of the disease the physician may decide to discontinue treatment for chorea

 

  • The drugs which may suppress the movement disorders associated with HD include tetrabenazine (Xenazine)

 

  • Antipsychotic drugs, such as haloperidol (Haldol) have a side effect of suppressing movements. Other agents that may help are diazepam (Valium), and some antiseizure drugs such as, clonazepam (Klonopin)

Back to Title

B) Medications for psychiatric symptoms:

Antidepressants and antipsychotics (for violent outbursts), may be required.

 

Medications:

Some of the medications used in the treatment of HD:

 

1-Image-Medication-Treatment-HD

 

Copyright © 2013 Innovate R&D

 

Back to Top
Risk Factors and Prevention:
  • If one parent has Huntington disease, then there is a 50 percent chance of a child developing the disease
  • Very rarely, one may develop Huntington disease without having a family history, it is suggested to be as a result of a genetic mutation during sperm development

 

Back to Top
Outcome:
  • There is no cure for Huntington disease
  • Progressive impairment
  • Life expectancy is ~15 to 20 years from diagnosis

 

Back to Top
 
Copyright © 2011-2017 Innovate R&D
stroke

educate Are you a Healthcare professional or patient?

Healthcare Professionals would include: Physicians (MD,OD), Physician assistants, Nurses, Pharmacists,Allied Health Workers (PT, OT, SLP, etc), Chiropractors, Paramedics, Optometrists, Dentists, Podiatrists etc, and students within these disciplines.

educate ** You are required to register **

eDucate is committed to optimizing the delivery of health information across the Healthcare continuum. To this end eDucate uses a wide array of learning tools, including Webinars, Quick Review Charts, Graphs, Brochures, Videos and Slide Presentations.

Professional Membership Benefits include free access to all archived and upcoming Webinars:

educate DISCLAIMER: This website is owned and operated by The Innovate Research and Development LP (Innovate R&D). All references herein to Innovate R&D shall be deemed to include any subsidiary, affiliate, associate or successor corporation of Innovate R&D. By entering and using this site, you agree to the "Terms of Use"for this website. If you do not agree to these terms and conditions then exit from this site immediately. Although Innovate R&D updates this website regularly with material believed to be accurate at the time of posting, Innovate R&D does not guarantee the accuracy, completeness, timeliness or currency of the material and consequently Innovate R&D expressly disclaims any liability for errors or omissions in the material contained in the website. The Innovate R&D website and all contents are provided as-is, and all representations and warranties, express or implied, relating to the website or the content are disclaimed, including any implied warranty of merchantability, fitness for a particular purpose or non-infringement, as well as any warranty of quality, functionality, accuracy, currency, completeness, reliability, operability, use performance or absence of viruses. In no way or event will Innovate R&D or any party that has been involved in the creation, production, promotion and marketing be liable to you or any other party for perceived direct or indirect damages. You assume all responsibility and risk of loss resulting from the use of our website.